Monoclonal antibodies in headache : from bench to patient / Antoinette Maassen van den Brink, Paolo Martelletti, editors.
Maassen van den Brink, Antoinette, editor.; Martelletti, Paolo, editor.
2021
RC392
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Monoclonal antibodies in headache : from bench to patient / Antoinette Maassen van den Brink, Paolo Martelletti, editors.
ISBN
9783030690328 (electronic bk.)
3030690326 (electronic bk.)
3030690318
9783030690311
DOI
https://doi.org/10.1007/978-3-030-69032-8
Published
Cham, Switzerland : Springer, [2021]
Language
English
Description
1 online resource (x, 172 pages) : color illustrations
Item Number
10.1007/978-3-030-69032-8 doi
Call Number
RC392
Dewey Decimal Classification
616.8/49106
Summary
Intended to promote a more appropriate and modern therapeutic approach to migraine management, this book is the first to deal with monoclonal antibodies in this context. Authored by the most respected migraine experts from around the globe and drawing on the lessons learned in both clinical trials and clinical practice, it reviews the current state of knowledge on this important therapeutic innovation, which has produced impressive data in randomized controlled trials, and the efficacy and safety of which have been confirmed in day-to-day real-world use. Given its scope, the book will appeal to a broad range of specialists, including pharmacologists, clinical pharmacologists, neurologists and internists, but also to residents and medical students.
Access Note
Access limited to authorized users.
Added Author
Maassen van den Brink, Antoinette, editor.
Martelletti, Paolo, editor.
Series
Headache (Springer (Firm)), 2197-652X
Available in Other Form
Print version: 9783030690311
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
The CGRP family of neuropeptides and their receptors in the trigeminovascular system
Pharmacology; where do the mAbs act, gepants vs mAbs
Monoclonal Antibody Biology
Guidelines for clinical trials
Human Models
CGRP Antibodies for Animal Models of Primary and Secondary Headache Disorders
Galcanezumab
Eptinezumab
Erenumab
Fremanezumab
Potential side effects and pregnancy
Real-world data, clinical practice so far
Migraine vs Cluster headache and potential other indications.

Browse Subjects

Show more subjects...

Statistics

from
to
Export